Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients
Authors:
- Amélie AnotaAAAmélie Anota
- Caroline Bascoul-MolleviCBCaroline Bascoul-Mollevi
- Thierry ConroyTCThierry Conroy
- Francis GuilleminFGFrancis Guillemin
- Michel VeltenMVMichel Velten
- Damien JollyDJDamien Jolly
- Mariette MercierMMMariette Mercier
- Sylvain CauseretSCSylvain Causeret
- Jean CuisenierJCJean Cuisenier
- Olivier GraesslinOGOlivier Graesslin
- Zeinab HamidouZHZeinab Hamidou
- Franck BonnetainFBFranck Bonnetain
Open Access
- 1 January 2014
- journal article
- research article
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 12 (1) , 32
Abstract
The occurrence of response shift (RS) in longitudinal health-related quality of life (HRQoL) studies, reflecting patient adaptation to disease, has already been demonstrated. Several methods have been developed to detect the three different types of response shift (RS), i.e. recalibration RS, 2) reprioritization RS, and 3) reconceptualization RS. We investigated two complementary methods that characterize the occurrence of RS: factor analysis, comprising Principal Component Analysis (PCA) and Multiple Correspondence Analysis (MCA), and a method of Item Response Theory (IRT). Breast cancer patients (n = 381) completed the EORTC QLQ-C30 and EORTC QLQ-BR23 questionnaires at baseline, immediately following surgery, and three and six months after surgery, according to the “then-test/post-test” design. Recalibration was explored using MCA and a model of IRT, called the Linear Logistic Model with Relaxed Assumptions (LLRA) using the then-test method. Principal Component Analysis (PCA) was used to explore reconceptualization and reprioritization. MCA highlighted the main profiles of recalibration: patients with high HRQoL level report a slightly worse HRQoL level retrospectively and vice versa. The LLRA model indicated a downward or upward recalibration for each dimension. At six months, the recalibration effect was statistically significant for 11/22 dimensions of the QLQ-C30 and BR23 according to the LLRA model (p ≤ 0.001). Regarding the QLQ-C30, PCA indicated a reprioritization of symptom scales and reconceptualization via an increased correlation between functional scales. Our findings demonstrate the usefulness of these analyses in characterizing the occurrence of RS. MCA and IRT model had convergent results with then-test method to characterize recalibration component of RS. PCA is an indirect method in investigating the reprioritization and reconceptualization components of RS.Keywords
This publication has 55 references indexed in Scilit:
- Response shift effects on measuring post-operative quality of life among breast cancer patients: a multicenter cohort studyQuality of Life Research, 2012
- Time to Deterioration in Quality of Life Score as a Modality of Longitudinal Analysis in Patients with Breast CancerThe Oncologist, 2011
- The king’s foot of patient-reported outcomes: current practices and new developments for the measurement of changeQuality of Life Research, 2011
- Health-related quality of life and cancer clinical trialsTherapeutic Advances in Medical Oncology, 2011
- Using structural equation modeling to detect response shift in performance and health-related quality of life scores of multiple sclerosis patientsQuality of Life Research, 2011
- Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinomaEuropean Journal of Cancer, 2010
- Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007Journal of Experimental & Clinical Cancer Research, 2008
- Response shift due to diagnosis and primary treatment of localized prostate cancer: a then-test and a vignette studyQuality of Life Research, 2007
- A Rasch and factor analysis of the Functional Assessment of Cancer Therapy-General (FACT-G)Health and Quality of Life Outcomes, 2007
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993